156 related articles for article (PubMed ID: 26714702)
1. Measuring T Cell-to-T Cell HIV-1 Transfer, Viral Fusion, and Infection Using Flow Cytometry.
Durham ND; Chen BK
Methods Mol Biol; 2016; 1354():21-38. PubMed ID: 26714702
[TBL] [Abstract][Full Text] [Related]
2. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses.
Chen P; Hübner W; Spinelli MA; Chen BK
J Virol; 2007 Nov; 81(22):12582-95. PubMed ID: 17728240
[TBL] [Abstract][Full Text] [Related]
3. Inefficient human immunodeficiency virus replication in mobile lymphocytes.
Sourisseau M; Sol-Foulon N; Porrot F; Blanchet F; Schwartz O
J Virol; 2007 Jan; 81(2):1000-12. PubMed ID: 17079292
[TBL] [Abstract][Full Text] [Related]
4. Ezrin is a component of the HIV-1 virological presynapse and contributes to the inhibition of cell-cell fusion.
Roy NH; Lambelé M; Chan J; Symeonides M; Thali M
J Virol; 2014 Jul; 88(13):7645-58. PubMed ID: 24760896
[TBL] [Abstract][Full Text] [Related]
5. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
Li H; Zony C; Chen P; Chen BK
J Virol; 2017 May; 91(9):. PubMed ID: 28148796
[TBL] [Abstract][Full Text] [Related]
6. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.
Cavrois M; De Noronha C; Greene WC
Nat Biotechnol; 2002 Nov; 20(11):1151-4. PubMed ID: 12355096
[TBL] [Abstract][Full Text] [Related]
7. Virological consequences of early events following cell-cell contact between human immunodeficiency virus type 1-infected and uninfected CD4+ cells.
Ruggiero E; Bona R; Muratori C; Federico M
J Virol; 2008 Aug; 82(16):7773-89. PubMed ID: 18508887
[TBL] [Abstract][Full Text] [Related]
8. A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry.
Esposito AM; Cheung P; Swartz TH; Li H; Tsibane T; Durham ND; Basler CF; Felsenfeld DP; Chen BK
Virology; 2016 Mar; 490():6-16. PubMed ID: 26803470
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion.
Cavrois M; Neidleman J; Yonemoto W; Fenard D; Greene WC
Virology; 2004 Oct; 328(1):36-44. PubMed ID: 15380356
[TBL] [Abstract][Full Text] [Related]
10. Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.
Massanella M; Puigdomènech I; Cabrera C; Fernandez-Figueras MT; Aucher A; Gaibelet G; Hudrisier D; García E; Bofill M; Clotet B; Blanco J
AIDS; 2009 Jan; 23(2):183-8. PubMed ID: 19098487
[TBL] [Abstract][Full Text] [Related]
11. The scaffolding protein Dlg1 is a negative regulator of cell-free virus infectivity but not of cell-to-cell HIV-1 transmission in T cells.
Nzounza P; Chazal M; Guedj C; Schmitt A; Massé JM; Randriamampita C; Pique C; Ramirez BC
PLoS One; 2012; 7(1):e30130. PubMed ID: 22272285
[TBL] [Abstract][Full Text] [Related]
12. Cell-to-Cell Spread of HIV and Viral Pathogenesis.
Law KM; Satija N; Esposito AM; Chen BK
Adv Virus Res; 2016; 95():43-85. PubMed ID: 27112280
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Gag, Envelope, and Extracellular Determinants Cooperate To Regulate the Stability and Turnover of Virological Synapses.
Gardiner JC; Mauer EJ; Sherer NM
J Virol; 2016 Jul; 90(14):6583-6597. PubMed ID: 27170746
[TBL] [Abstract][Full Text] [Related]
14. Tracking and quantitation of fluorescent HIV during cell-to-cell transmission.
Dale BM; McNerney GP; Hübner W; Huser TR; Chen BK
Methods; 2011 Jan; 53(1):20-6. PubMed ID: 20627127
[TBL] [Abstract][Full Text] [Related]
15. A clathrin-dynamin-dependent endocytic pathway for the uptake of HIV-1 by direct T cell-T cell transmission.
Bosch B; Grigorov B; Senserrich J; Clotet B; Darlix JL; Muriaux D; Este JA
Antiviral Res; 2008 Nov; 80(2):185-93. PubMed ID: 18602423
[TBL] [Abstract][Full Text] [Related]
16. Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1.
Jolly C; Mitar I; Sattentau QJ
J Virol; 2007 Jun; 81(11):5547-60. PubMed ID: 17360745
[TBL] [Abstract][Full Text] [Related]
17. A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity.
Sánchez-Palomino S; Massanella M; Carrillo J; García A; García F; González N; Merino A; Alcamí J; Bofill M; Yuste E; Gatell JM; Clotet B; Blanco J
Vaccine; 2011 Jul; 29(32):5250-9. PubMed ID: 21609746
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE
J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259
[TBL] [Abstract][Full Text] [Related]
19. Visualization of HIV T Cell Virological Synapses and Virus-Containing Compartments by Three-Dimensional Correlative Light and Electron Microscopy.
Wang L; Eng ET; Law K; Gordon RE; Rice WJ; Chen BK
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847357
[TBL] [Abstract][Full Text] [Related]
20. Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors.
Mazurov D; Ilinskaya A; Heidecker G; Lloyd P; Derse D
PLoS Pathog; 2010 Feb; 6(2):e1000788. PubMed ID: 20195464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
